Experience

• Represented Becton Dickinson, a global medical technology company, in a number of divestitures and acquisitions, including in its recently announced sale of its Discovery Labware unit.
• Represented Pfizer, the world's largest research-based pharmaceutical company, in its acquisition of Excaliard Pharmaceuticals, a biopharmaceutical company focused on the development of novel drugs for the treatment of skin scarring.
• Represented the lead underwriters in the initial public offering of M/A-Com Technology Solutions, a leading supplier of high performance analog semiconductor solutions for use in radio frequency (RF), microwave, and millimeter wave applications.
• Represented LPL Financial Holdings, the holding company for one of the largest brokerage firms in the U.S., in its $522 million initial public offering and subsequent follow on offerings.
• Represented Green Mountain Coffee Roasters, a provider and marketer of coffee in the United States and internationally, in its recent $610 million follow on equity offering.
• Represented Covidien, a leading global provider of health care products, in several acquisitions, including in its acquisitions of ev3 and Aspect Medical Systems.
• Represented URL Pharma, a Philadelphia-based specialty drug company, in its announced sale to Takeda Pharmaceutical Company for $800 million plus contingent earn-out payments.
• Represented a number of clients in the negotiation of various power and energy contracts, including in the renewable energy sector.